Yahoo Finance • 12 months ago
HAYWARD, Calif., November 15, 2023--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment o... Full story
Yahoo Finance • last year
Pulse Biosciences will host a conference call at 9:00 am PT / 12:00 pm ET on Monday, November 13, 2023 HAYWARD, Calif., November 10, 2023--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE, "the Company"), a company primarily focused... Full story
Yahoo Finance • last year
HAYWARD, Calif., May 18, 2023--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today anno... Full story
Yahoo Finance • 2 years ago
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2023 Earnings Call Transcript May 11, 2023 Pulse Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.23 EPS, expectations were $-0.22. Operator: Good afternoon, ladies and gentl... Full story
Yahoo Finance • 2 years ago
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2022 Earnings Call Transcript March 30, 2023 Operator: Ladies and gentlemen, greetings, and welcome to the Pulse Biosciences' Fourth Quarter 2022 Earnings Conference Call. At this time all particip... Full story
Yahoo Finance • 3 years ago
U.S. biotechs and other health care stocks accounted for about 11% of all losses in U.S. equity values during the five-month period analyzed by The Business Journals.... Full story
Yahoo Finance • 3 years ago
HAYWARD, Calif., May 11, 2022--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced financial... Full story
Yahoo Finance • 3 years ago
NEW YORK, April 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive... Full story
Yahoo Finance • 3 years ago
BENSALEM, Pa., April 15, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story
Yahoo Finance • 3 years ago
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy o... Full story
Yahoo Finance • 3 years ago
NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Acutus Medical, Inc. (NA... Full story
Yahoo Finance • 3 years ago
NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive... Full story
Yahoo Finance • 3 years ago
LOS ANGELES, April 07, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased... Full story
Yahoo Finance • 3 years ago
NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fennec Pharmaceuticals,... Full story
Yahoo Finance • 3 years ago
NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive... Full story
Yahoo Finance • 3 years ago
NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Pulse Biosciences, Inc.... Full story
Yahoo Finance • 3 years ago
HAYWARD, Calif., March 31, 2022--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced financi... Full story
Yahoo Finance • 3 years ago
紐約, March 30, 2022 (GLOBE NEWSWIRE) -- 為何︰全球投資者權益律師事務所 Rosen Law Firm 提醒在 2021 年 1 月 12 日至 2022 年 2 月 7 日(包括首尾兩天)期間(「集體訴訟期間」)購買 Pulse Biosciences, Inc. (NASDAQ: PLSE) 證券的購買者注意,2022 年 4 月 18 日是首席原告人截止日期的重要日子。 何事:如果您在集體訴訟期間購買了 Pulse 證券,您可... Full story
Yahoo Finance • 3 years ago
NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive... Full story
Yahoo Finance • 3 years ago
LOS ANGELES, March 28, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story